Molecular Imaging

Alzheimer’s could be diagnosed earlier if the blood-brain barrier was monitored as a biomarker and…
BlueCross BlueShield of Tennessee announced it will expand Medicare coverage for cardiac PET,…
In patients with diagnosed Alzheimer’s disease (AD), [18F] flortaucipir PET imaging proved accurate…
Amyloid load (AβL) imaged in vivo using [18F]Florbetapir PET is a more sensitive biomarker for…
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the American Society of Nuclear…
Authors of a recent Journal of Nuclear Medicine study have discovered potential for misdiagnosis…
Researchers from the Salk Institute in San Diego and the University of Florida have used cryo-…
A German-led research team has developed a new nuclear medicine imaging technique that outperforms…
Using patient-specific body weight-based protocols during whole-body fluorodeoxyglucose (18F-FDG)…
For patients with Alzheimer’s disease, amyloid PET imaging can improve diagnosis, diagnostic…
Aetna announced, Thursday, Aug. 16, it will expand its coverage of the PET tracer gallium-68 (Ga-68…
Extending PET acquisition time during PET/MRI for rectal cancer staging increases identified lymph…